EDIT:NASDAQ
Editas Medicine Inc
$2.57
arrow_upward
+0.78%(+0.020) 1D
$2.57
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.33M
Volume
1.72M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Investor's Business Daily
·
27 minutes ago
Futures Loom; Nvidia Probes CEO Huang Espionage Reports
Cryptonews.net
·
32 minutes ago
XRP Price Prediction: Analyst Warns of $0.80 Crash if S&P 500 Breaks Key Support
Yahoo Finance
·
4 hours ago
Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More
Benzinga
·
3 hours ago
Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com